Skip to main content

Table 4 Multivariate analyses of various clinical parameters in prostate cancer patients

From: Pretreatment elevated prognostic nutritional index predicts a favorable prognosis in patients with prostate cancer

ParametersProgression-Free SurvivalCancer-Specific SurvivalOverall Survival
HR (95% CI)P-valueHR (95% CI)P-valueHR (95% CI)P-value
Age (years)0.975 (0.953–0.997)0.028  
Gleason Score < 0.001 < 0.001 < 0.001
  ≤ 71 1 1 
  > 72.392 (1.638–3.495 5.073 (2.569–10.020) 4.003 (2.298–6.974) 
Metastasis < 0.001 < 0.001 < 0.001
 No1 1 1 
 Yes2.930 (2.021–4.247) 6.091 (3.086–12.024) 3.245 (1.957–5.378) 
PNI 0.001 0.002 0.001
  < 50.21 1 1 
  ≥ 50.20.521 (0.355–0.765) 0.421 (0.243–0.728) 0.429 (0.263–0.698) 
  1. Abbreviations: HR Hazard ratio; CI Confidence interval; PSA Prostate-specific antigen; PNI Prognostic nutritional index